Cargando…
Temozolomide-Induced Shrinkage of a Pituitary Carcinoma Causing Cushing's Disease — Report of a Case and Literature Review
Temozolomide (TMZ) is an alkylating chemotherapeutic agent that has recently been used in some cases as a new therapeutic tool for pituitary carcinomas and aggressive pituitary adenomas. In this report, we present the case of effective TMZ treatment in a 42-year-old man with ACTH-secreting carcinoma...
Autores principales: | Curtò, Lorenzo, Torre, Maria L., Ferraù, Francesco, Pitini, Vincenzo, Altavilla, Giuseppe, Granata, Francesca, Longo, Marcello, Hofland, Leo J., Trimarchi, Francesco, Cannavò, Salvatore |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
TheScientificWorldJOURNAL
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763678/ https://www.ncbi.nlm.nih.gov/pubmed/21057727 http://dx.doi.org/10.1100/tsw.2010.210 |
Ejemplares similares
-
Shrinkage of a pituitary metastasis of melanoma induced by pembrolizumab: a case report
por: Giuffrida, Giuseppe, et al.
Publicado: (2021) -
Multidisciplinary Management of Pituitary Apoplexy
por: Albani, Adriana, et al.
Publicado: (2016) -
Temozolomide therapy: Focus on patients with pituitary carcinoma
por: Curtò, Lorenzo
Publicado: (2016) -
Lymphocytic Hypophysitis: Differential Diagnosis and Effects of High-Dose Pulse Steroids, Followed by Azathioprine, on the Pituitary Mass and Endocrine Abnormalities — Report of a Case and Literature Review
por: Curtò, Lorenzo, et al.
Publicado: (2010) -
Commentary on “Co-Occurrence of Pituitary Adenoma With Suprasellar and Olfactory Groove Meningiomas”
por: Curtò, Lorenzo, et al.
Publicado: (2017)